Significant improvement of a nevus spilus-type congenital melanocytic nevus with oral selumetinib.
Pediatr Dermatol
; 2024 Jun 17.
Article
in En
| MEDLINE
| ID: mdl-38886992
ABSTRACT
Giant congenital melanocytic nevi (GCMN) can be cosmetically significant and can lead to melanoma. There is no standard pharmacologic treatment for GCMN. We present the case of an 8-year-old female with kaposiform lymphangiomatosis caused by an NRAS mutation whose nevus spilus-type GCMN improved on oral selumetinib.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Pediatr Dermatol
Year:
2024
Document type:
Article
Affiliation country:
United States